Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

4drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: CAB/RPV-LA ×

CAB/RPV-LA

This drug is selected. Its supporting articles are shown below.

CAB/RPV-LA1

Articles mentioning CAB/RPV-LA

1 articles · page 1 of 1

OC41 Long-term follow-up to 96 weeks of long-acting cabotegravir/rilpivirine: sustained reduction of immune activation and senescence in people living with HIV and CMV co-infection

sextrans · abstract · 2026-06-05 · 4 matching annotations

84.8%

cabotegravir/rilpivirine CAB/RPV-LA HIV PWH-CG HIV-RNA PWH PWH-LA ART

…scence markers in people with HIV(PWH) switching to long-acting cabotegravir/rilpivirine (CAB/RPV-LA), compared with PWH continuing oral ART, extending …

Browse drugs

CAB/RPV-LA

Articles mentioning CAB/RPV-LA

OC41 Long-term follow-up to 96 weeks of long-acting cabotegravir/rilpivirine: sustained reduction of immune activation and senescence in people living with HIV and CMV co-infection